| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |